Clinical Trial Update: Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated an allometric miltefosine dosing strategy for visceral leishmaniasis in children in Eastern Africa, focusing on pharmacokinetics and saf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visceral Leishmaniasis

Drugs mentioned

• Miltefosine (miltefosine)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Visceral Leishmaniasis | Phase 2 | Status: COMPLETED